Results for tag: "Zolinza"

Zolinza (vorinostat) is a drug used to treat cutaneous T-cell lymphoma (CTCL), a type of non-Hodgkin lymphoma. It is a histone deacetylase inhibitor, meaning it works by blocking the activity of an enzyme that helps cancer cells grow and divide. Zolinza is the only FDA-approved drug for CTCL and is available in both oral and intravenous forms. The Zolinza market is composed of a variety of companies, including pharmaceutical companies, biotechnology companies, and generic drug manufacturers. These companies are involved in the research, development, and marketing of Zolinza. They are also responsible for the production and distribution of the drug. Some of the companies in the Zolinza market include Merck & Co., Inc., Novartis AG, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. These companies are involved in the research, development, and marketing of Zolinza, as well as the production and distribution of the drug. Show Less Read more